Back to Journals » International Journal of Nanomedicine » Volume 17

In vitro and in vivo Protein Release and Anti-Ischemia/Reperfusion Injury Properties of Bone Morphogenetic Protein-2-Loaded Glycyrrhetinic Acid-Poly(Ethylene Glycol)-b-Poly(L-Lysine) Nanoparticles [Retraction]

Authors Shan F, Liu Y, Jiang H, Tong F 

Received 8 June 2022

Accepted for publication 8 June 2022

Published 10 June 2022 Volume 2022:17 Pages 2609—2610


Shan F, Liu Y, Jiang H, Tong F. Int J Nanomedicine. 2017;12:7613–7625.

The Editor and Publisher of International Journal of Nanomedicine wish to retract the published article. Concerns were raised regarding the alleged manipulation of the in vitro transfection images shown in Figure 4C and the duplication of histopathological images shown in Figure 5A.

The authors responded to our queries and explained the fluorescent images collected for Figure 4C had mistakenly been superimposed on top of each other and the duplication of images in Figure 5Ab and 5Ac had occurred inadvertently during the figure preparation. The authors also provided original data for the figures in question. However, the author’s explanation and the provided data was not satisfactory, and the Editor requested for the article to be retracted. The authors were notified of this decision.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.